SynthesisFrontiers in pharmacology2022

Cardiovascular adverse events associated with cyclophosphamide, pegylated liposomal doxorubicin, vincristine, and prednisone with or without rituximab ((R)-CDOP) in non-Hodgkin's lymphoma: A systematic review and meta-analysis.

Bin Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.